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Abstract
Background: Preterm birth is certainly a public health problem. Aside 
from being an important cause of mortality, prematurity increases the risk of 
serious lifetime disabilities.
Objective: To assess the overall survival, causes of death and neonatal 
morbidities associated with prematurity of newborns less than 29 weeks of 
gestational age (GA).
Methods: Retrospective study including all preterm infants less than 29 
weeks of GA admitted to the level III Neonatal Intensive Care Unit (NICU) 
at Centro Hospital São João in Porto, Portugal, between January 1st, 2005 and 
December 31st, 2016. Newborns were grouped into three groups according to 
their GA: G23+0-24+6, G25+0-26+6, G27+0-28+6.
Results: In this 12-year-period, 160 preterm neonates less than 29 weeks 
of GA admitted to this NICU met our inclusion criteria. Overall deaths were 
60 (37.5%), variating between 25 (92.6%) in the G23+0-24+6, 23 (46%) in the 
G25+0-26+6 and 12 (14.5%) in the G27+0-28+6. The leading causes of death 
were intraventricular hemorrhage (IVH) and sepsis. Early neonatal mortality 
was 20.6%. Among survivors, 41% had bronchopulmonary dysplasia (BPD), 
69% developed late sepsis, 56% retinopathy of prematurity (ROP), 44% IVH 
and 10% cystic periventricular leukomalacia (cPVL).
Conclusions: Mortality rates in this preterm group were high in spite of all 
the technological and scientific advances. Pulmonary conditions (respiratory 
distress syndrome and BPD), sepsis and neurologic outcomes (ROP, IVH 
and cPVL) were still major causes of morbidity. In line with other series, the 
limit of viability in this cohort of preterm infants is 25 weeks of GA. Prenatal, 
perinatal and postnatal care still all have a long road ahead, especially when 
it comes to these “gray zone” newborns. 
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Introduction
Preterm birth is certainly a public health 
problem. According to the World Health 
Organization (WHO), prematurity is the leading 
cause of death among newborns and it comes in 
second between children below five years old, 
after pneumonia. Aside from being an important 
cause of mortality, premature birth increases the 
risk of serious lifetime disabilities [1].
Prematurity and its poor outcomes not only 
occur at high rates in undeveloped countries but 
also have a significant impact in the more developed 
ones. In Portugal, for instance, 7.8% of all children 
born in 2016 were preterm, and 2.3/1,000 babies 
died before 28 days of life [2].
The limit of viability has been considerably 
decreasing from 31 weeks in 1960 to 23 weeks 
of gestational age (GA) nowadays [3], due 
to improvements in advanced life support 
technologies. However, this increase in survival 
rate has consequently raised the absolute number 
of premature infants with chronic morbidities.
There are numerous ways to fight these 
devastating outcomes of preterm newborns. One 
of them is to prevent preterm births through 
preconception and antenatal care; another one is 
to increase neonatal care quality, mainly in the 
Neonatal Intensive Care Units (NICUs).
A systematic review showed that there is still 
a wide variation of recommendations among 
countries, although with an overall agreement for 
comfort care at 22 weeks of GA and active care at 
25 weeks of GA [4].
The aim of this study was to assess the overall 
survival, causes of death and neonatal morbidities 
associated with prematurity of newborns less than 
29 weeks of GA, in a level III NICU.
Methods
We conducted a retrospective study including 
all preterm infants born with less than 29 weeks 
of GA who were admitted to the level III NICU 
at hospital São João in Porto, Portugal, one of the 
20 level III hospitals in the country. Data were 
collected from the past 12 years, between January 
1st, 2005 and December 31st, 2016. We decided 
to exclude all newborns admitted after 72 hours 
of life and also those transferred to other centers 
before their first week of life. Clinical data, 
including demographic, obstetric and neonatal 
were collected through a retrospective search of 
the medical records available either on paper or 
electronic database.
GA was assessed by menstrual age (regular 
menstrual cycles), obstetric ultrasound examination 
[5] or the New Ballard Score (in the absence of 
obstetric data) [6]. Fetal growth restriction was 
defined as a birth weight below the 10th percentile 
of Fenton’s fetal growth charts [7].
In this center, antenatal steroid regimen is 
performed with betamethasone since 2003 in 
pregnancies below 25 weeks of GA, in which 
preterm birth is a possibility [8].
We collected data on several conditions 
associated with prematurity. Respiratory distress 
syndrome (RDS) was diagnosed according to 
the European Consensus Guidelines on the 
Management of Neonatal Respiratory Distress 
Syndrome: PaO
2
 < 50 mmHg in room air, central 
cyanosis in room air, need for supplemental oxygen 
to maintain PaO
2
 > 50 mmHg or to maintain a 
pulse oximeter saturation > 85% within the first 
24 hours of life; and as well as the classical chest 
radiograph (including a ground-glass appearance 
and air bronchogram). Nonetheless, this classic 
patterns of RDS are rarely seen today due to early 
surfactant therapy and early continuous positive 
air pressure (CPAP) [9-11]. Newborns were 
accessed at 36 weeks of GA or at discharge to 
determine whether they had bronchopulmonary 
dysplasia (BPD). BPD was defined as treatment 
with supplemental oxygen for at least 28 days and 
classified in mild, moderate or severe according 
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to the National Institute of Child Health and 
Human Development (NICHD) [12]. Pulmonary 
hemorrhage and pneumonia were diagnosed based 
on clinical and radiological findings, the latter 
being also based on a microbiological culture. 
Hemodynamically significant patent ductus ar-
teriosus (PDA) was diagnosed between 24 and 
72 hours of life based on clinical symptoms and 
echocardiographic findings. The infants were 
treated with indomethacin before 2010 and with 
ibuprofen afterward or with surgical closure when 
medical treatment failed or was contraindicated. 
We defined and staged necrotizing enterocolitis 
(NEC) according to Bell’s criteria [13]. Early 
and late-onset sepsis were considered when there 
were evident clinical symptoms of sepsis and a 
positive C-reactive protein, confirmed or not with 
a positive blood culture, before or after the first 
72 hours of life. The diagnosis and grading of 
intraventricular hemorrhage (IVH) were based 
on Papile’s [14] or Volpe’s [15] classification 
depending on the year of birth (before or after 
2010, respectively) and grade III and IV were 
considered severe. Cystic periventricular leuko-
malacia (cPVL) was classified according to De 
Vries [16]. Retinopathy of prematurity (ROP) 
was diagnosed and classified according to the 
international classification [17].
We also registered all management and 
mortality information. Necropsy data of deceased 
neonates were also registered and analyzed, 
whenever parents authorized it. 
We divided the newborns into three groups 
of two weeks of age each according to their 
GA: G23+0-24+6, G25+0-26+6, and G27+0-28+6. We 
focused our study on data after 2005 because there 
were a few major changes in the NICU concerning 
the management of preterm newborns [8].
This study was approved by the Ethics 
Committee of Centro Hospitalar São João, number 
180-17.
Data were statistically analyzed using SPSS® 
version 24 IBM® software.
It was considered statistically significant a 
p-value ≤ 0.05. Categorical variables are presented 
as percentages and numerical variables as median 
with an inter-quartile range. Univariate analysis 
comprised the Mann-Whitney U-test or Kruskal-
Wallis to compare groups for numerical variables 
and the Chi-square test or Fisher’s exact test for 
categorical variables. 
A multivariate analysis was conducted to identify 
predictors of death, with a 95% confidence interval 
(CI). Logistic regression models were constructed 
beforehand, including all covariates identified in the 
univariate analysis with p-value < 0.1.
Results
About 3,000 newborns are born at Centro 
Hospital São João each year, and 450 are admitted 
to its level III NICU, including both inborn and 
outborn infants. In our 12-year-period, 160 preterms 
with less than 29 weeks of GA were admitted to the 
NICU and met our inclusion criteria.
Among the 160 neonates, 74 (46.3%) were 
female and 112 (70%) were singletons. Mother’s 
median age was 31 years, and 60.6% of the babies 
were delivered by a cesarean section (C-section), 
a high rate which does not mirror the global rates 
of this country, currently about 30%. Prenatal 
corticosteroids were administered to 141 (91.6%), 
Tab. 1.
Everyone received supplemental oxygen and 
ventilation, either with nasal continuous positive 
airway pressure (nCPAP) or with invasive 
mechanical ventilation (IMV). Over these 12 years, 
we found a trend to decrease the endotracheal 
intubation in the delivery room from 97% before 
2010 to 89% afterward, p = 0.059. In this study, 
we did not find any significant difference between 
the use of IMV, being 91.2% and 88%, before 
and after 2010, respectively. Surfactant therapy 
was administered to 150 (94.9%) preterm infants. 
Dopamine was administered to 16 (61.5%) and 26 
(52%) in the first two groups (G23+0-24+6 and G25+0-
26+6, respectively), and to 26 (31.3%) in the third 
group (G27+0-28+6). Based on the data we collected, 
all infants received antibiotics (Tab. 2).
Overall deaths were 60 (37.5%), variating 
between 25 (92.6%) in the G23+0-24+6, 23 (46%) in 
the G25+0-26+6 and 12 (14.5%) in the G27+0-28+6. 
The leading causes of death were IVH and sepsis. 
Early neonatal mortality was 20.6%, and 45.5% 
of these newborns died because of pulmonary 
hypoplasia (Tab. 3).
In a logistic regression followed by a 
multivariable analysis, death was significantly 
associated with GA (B = 0.355; 95% CI = 0.226-
0.557; p < 0.0005) and birth weight (B = 0.996; CI 
= 0.993-0.999; p < 0.0005) but not with prenatal 
steroids or surfactant (p > 0.05). Based on the B 
value = 0.355, the chances of death decrease 64.5% 
for each additional week of GA.
Global rates of RDS were close to 89% and BPD 
was seen in 35 (21.9%) of all infants included in the 
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Table 1. Maternal and newborn’s demographics and perinatal clinical data.
GA (weeks) Total(n = 160)
23+0-24+6
(n = 27)
25+0-26+6
(n = 50)
27+0-28+6
(n = 83) p
Mother’s age, median (IQR) 31 (28-35) 32 (31-36) 31 (28-33) 31 (28-35) 0.246 b
Gender
0.683 a• Male, n (%) 86 (53.8) 16 (59.3) 28 (56.0) 42 (50.6)
• Female, n (%) 74 (46.3) 11 (40.7) 22 (44.0) 41 (49.4)
BW (g), median (IQR) 835 (690-1,000) 650 (560-700) 790 (700-880) 985 (805-1,150) < 0.0005 b
Fetal growth restriction, n (%) 30 (18.8) 3 (11.1) 8 (16.0) 19 (22.9) 0.330 a
Parity
0.006 a• Single, n (%) 112 (70.0) 12 (44.4) 37 (74.0) 63 (75.9)
• Multiple, n (%) 48 (30.0) 15 (55.6) 13 (26.0) 20 (24.1)
Delivery
< 0.0005 a• C-section, n (%) 97 (60.6) 3 (11.1) 30 (60.0) 64 (77.1)
Prenatal steroids, n (%) 141 (91.6) 19 (73.1) 44 (95.7) 78 (95.1) 0.004 c
• Full cycle, n (%) 109 (77.3) 11 (57.9) 34 (77.3) 64 (82.1) 0.079 a
Mother’s infection, n (%) 28 (17.6) 2 (7.4) 8 (16.0) 18 (22.0) 0.213 a
Antibiotic use, n (%) 63 (39.4) 6 (22.2) 16 (32.0) 41 (49.4) 0.019 a
Mother’s disease, n (%)
• Autoimmune disease 4 (2.5) 0 (0.0) 0 (0.0) 4 (4.8) 0.293 c
• Arterial hypertension 10 (6.3) 1 (3.7) 1 (2.0) 8 (9.6) 0.195 c
• Gestational diabetes 14 (8.8) 2 (7.4) 10 (20.0) 2 (2.4) 0.002 c
• Preeclampsia 24 (15.1) 1 (3.7) 5 (10.2) 18 (21.7) 0.035 a
• Eclampsia 1 (0.6) 0 (0.0) 0 (0.0) 1 (1.2)
• HELLP dyndrome 6 (3.8) 0 (0.0) 3 (6.0) 3 (3.6) 0.633 c
• Placental abruption 21 (13.1) 1 (3.7) 9 (18.0) 11 (13.3) 0.208 a
ROM > 18 hours, n (%) 27 (17.0) 3 (11.1) 7 (14.0) 17 (20.7) 0.408 a
Apgar score, n (%)
• 1st minute < 7 108 (68.4) 25 (100.0) 37 (74.0) 46 (55.4) < 0.0005 a
• 5th minute < 7 58 (36.5) 15 (57.7) 21 (42.0) 22 (26.5) 0.01 a
• 10th minute < 7 13 (9.8) 6 (42.9) 3 (7.7) 4 (5.1) < 0.001 c
Please note that in some cases data is missing.
BW: birth weight; GA: gestational age; IQR: interquartile range; ROM: rupture of membranes.
a Chi-square test; b Kruskal-Wallis test; c Fisher’s exact test.
Table 2. Management data of the newborns.
GA (weeks) Total(n = 160)
23+0-24+6
(n = 27)
25+0-26+6
(n = 50)
27+0-28+6
(n = 83) p
Resuscitation, n (%) 153 (95.6) 26 (96.3) 49 (98.0) 78 (94.0) 0.681 c
• Endotracheal tube, n (%) 141 (92.2) 26 (100) 45 (91.8) 70 (89.7) 0.258 c
Surfactant use, n (%) 150 (94.9) 27 (100) 49 (98.0) 74 (91.4) 0.118 c
• No. of doses, median (IQR) 2 (1-2) 2 (1.75-2.25) 2 (2-3) 2 (1-2) 0.028 b
• < 1st hour after birth, n (%) 67 (49.3) 15 (78.9) 23 (51.1) 29 (40.3) 0.011 a
Supplemental oxygen, n (%) 160 (100) 27 (100) 50 (100) 83 (100) -
• Days O2, median (IQR) 15 (4-50) 5 (1-17) 34 (8-75) 15 (4-44) < 0.0005 b
• FiO2 max, median (IQR) 45 (30-80) 100 (60-100) 60 (45-100) 30 (21-50) < 0.0005 b
Ventilation, n (%) 160 (100) 27 (100) 50 (100) 83 (100) -
• nCPAP, n (%) 113 (70.6) 4 (14.8) 33 (66.0) 76 (91.6) < 0.0005 a
• Days of therapy, median (IQR) 31 (17-45) 23 (4-44) 31 (12-45) 31 (22-46) 0.287 b
• IMV, n (%) 143 (89.4) 27 (100) 48 (96.0) 68 (81.9) 0.038 c
• Days of therapy, median (IQR) 8 (4-25) 4 (1-17) 21 (8-35) 7 (4-17) < 0.0005 b
Vasoactive amines use, n (%) 68 (42.8) 16 (61.5) 26 (52.0) 26 (31.3) 0.007 a
Antibiotic treatment, n (%) 156 (100) 25 (100) 49 (100) 82 (100) -
• No. of cycles, median (IQR) 2 (1-4) 1 (1-2) 3 (2-4) 2 (2-4) 0.0005 b
Transfusions
• Erythocytes, n (%) 115 (71.9) 18 (66.7) 44 (88) 53 (63.7) 0.009 a
• No., median (IQR) 3 (2-7) 3 (1-7) 5 (3-9) 3 (2-5) < 0.001 b
• Platelets, n (%) 57 (35.6) 10 (37.0) 29 (58.0) 18 (21.7) < 0.0005 a
• No., median (IQR) 3 (1-5) 4 (2-7) 2 (1-5) 3 (1-4) 0.917 b
Please note that in some cases data is missing. 
GA: gestational age; IMV: invasive mechanical ventilation; IQR: interquartile range; nCPAP: nasal continuous positive airway pressure.
a Chi-square test; b Kruskal-Wallis test; c Fisher’s exact test.
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study. Nosocomial sepsis was present in 89 (55.6%) 
and PDA in 84 (52.8%). When it comes to brain 
damage, IVH occurred in 69 (43.1%), 41 (59.4%) 
of them classified as severe IVH, while 27 (16.9%) 
developed cPVL.
In this study, survival without major morbidity 
was 5%. Among survivors, 41 (41%) had BPD, 
mostly mild or moderate. Between the 52 (52%) 
with PDA, 39 (78%) were treated medically. 
Fifty-six babies (56.0%) were discharged with 
ROP, 24 (42.9%) classified as severe ROP (grade 
2 or higher). Sixteen of them were born with 25 
or 26 weeks. Severe NEC was diagnosed in 14 
(14%) premature infants, 11 of them belonging 
to G27+0-28+6. Forty-four (44%) had IVH, 19 
(43.2%) of them classified as severe. Median 
NICU stay was around 70 days, ranging from 93 
or 97 days in the first two groups to 63 days in the 
third group (Tab. 4).
Discussion 
In this study, we analyzed the neonatal mortality 
and morbidities of a cohort of preterm infants less 
than 29 weeks of GA.
A study comparing nine countries in Europe, 
showed that Portugal had one of the lowest preterm 
natality rates and it was ranked fifth in the adjusted 
neonatal death rate [18].
Implementation of regionalized perinatal care 
and high-quality NICUs, along with advances in 
areas such as technology or delivery assistance 
have allowed major improvements in pediatric life 
support [19]. Therefore, as expected, the mortality 
rates have decreased over the years. Specifically in 
this level III NICU which belongs to the pediatric 
service of a university hospital in Porto, Portugal, 
the mortality rates of premature infants less than 29 
weeks of GA was around 52% in the nineties [20], 
contrasting with the 37.5% verified in our 2005 to 
2016 cohort. Nevertheless, this increase in survival 
does not necessarily come along with a reduction 
of morbidities, particularly neurological sequelae 
[19]. This mortality rate is slightly higher than in 
other countries [21], although we should consider 
that we included in this study only preterm infants 
born before 29 weeks of GA. 
Overall early neonatal mortality was 20.6%. 
We registered that in the G23+0-24+6, death 
was much more prevalent in the first week than 
Table 3. Mortality and causes of death.
GA (weeks) Total(n = 160)
23+0-24+6
(n = 27)
25+0-26+6
(n = 50)
27+0-28+6
(n = 83) p
Deceased, n (%) 60 (37.5) 25 (92.6) 23 (46.0) 12 (14.5) < 0.0005 a
Causes of death
• Pulmonary hypoplasia, n (%) 16 (26.7) 12 (48.0) 2 (8.7) 2 (16.7)
• Pulmonary hemorrhage, n (%) 3 (5.0) 1 (4.0) 1 (4.3) 1 (8.3)
• Pneumonia, n (%) 3 (5.0) 0 (0.0) 2 (8.7) 1 (8.3)
• Sepsis, n (%) 18 (30.0) 6 (24.0) 8 (34.8) 4 (33.3)
• Congenital heart disease, n (%) 2 (3.3) 0 (0.0) 1 (4.3) 1 (8.3)
• IVH, n (%) 18 (30.0) 6 (24.0) 9 (39.1) 3 (25.0)
Early neonatal mortality, n (%) 33 (20.6) 17 (62.9) 7 (14.0) 9 (10.8) < 0.05 b
Causes of death
• Pulmonary hypoplasia, n (%) 15 (45.5) 12 (70.6) 1 (14.3) 2 (22.2)
• Pulmonary hemorrhage, n (%) 3 (9.1) 1 (5.9) 1 (14.3) 1 (11.1)
• Pneumonia, n (%) 1 (3.0) 0 (0.0) 0 (0.0) 1 (11.1)
• Sepsis, n (%) 3 (9.1) 1 (5.9) 0 (0.0) 2 (11.1)
• Congenital heart disease, n (%) 2 (3.3) 0 (0.0) 1 (14.3) 1 (11.1)
• IVH, n (%) 9 (27.3) 3 (17.6) 4 (57.1) 2 (22.2)
Late neonatal mortality, n (%) 21 (13.1) 7 (25.9) 12 (24.0) 2 (2.4) < 0.05 b
Causes of death
• Pulmonary hypoplasia, n (%) 1 (4.8) 0 (0.0) 1 (8.3) 0 (0.0)
• Pneumonia, n (%) 2 (9.5) 0 (0.0) 2 (16.7) 0 (0.0)
• Sepsis, n (%) 10 (47.6) 4 (57.1) 5 (41.6) 1 (50.0)
• IVH, n (%) 8 (38.1) 3 (42.9) 4 (33.3) 1 (50.0)
Postneonatal mortality c, n (%) 6 (3.8) 1 (3.7) 4 (8.0) 1 (1.2) > 0.05 b
Causes of death
• Sepsis, n (%) 5 (83.3) 1 (100) 3 (75.0) 1 (100)
• IVH, n (%) 1 (16.7) 0 (0.0) 1 (25.0) 0 (0.0)
Please note that in some cases data is missing.
GA: gestational age; IVH: intraventricular hemorrhage.
a Chi-square test; b Chi-square test, using Bonferroni correction; c death occurring after the 28th day until discharge.
6/9 Marques • Dinis • Rocha • Flôr-de-Lima • Matos • Henriques • Guimarães
Journal of Pediatric and Neonatal Individualized Medicine • vol. 8 • n. 1 • 2019www.jpnim.com Open Access
afterward (62.9% vs. 25.9%). On the other hand, 
the majority of those born with 25 or 26 weeks 
of GA died after the first seven days (24.0% vs. 
14.0%). This might be explained by the causes of 
death observed in these groups with different GAs 
and consequently with different morbidities. The 
main cause of death in neonates born with 23 or 24 
weeks of GA was pulmonary hypoplasia, which is 
a condition directly associated with their very low 
GA. The dominant cause of late neonatal death in 
the G25+0-26+6 was sepsis, a condition not directly 
involved with the GA but significantly related 
with a longer stay in the NICU and, of course, with 
the vulnerability of each newborn [22]. Among 
survivors, it is also clear that nosocomial sepsis 
decreases with GA, meeting our expectations. In 
2010, this NICU changed some protocols in order 
to prevent nosocomial sepsis, and its rates have 
been decreasing since then [22]. In the management 
of these preterm infants we continue to implement 
better practices to increase more and more the 
survival without increasing their morbidities.
As mentioned before, the leading causes of 
death were IVH and sepsis, both contributing 
individually to 30% of all deaths. Infectious causes 
were also responsible for 30% of deaths in a cohort 
of extremely low birth weight (ELBW) infants 
from 1996 to 2014 in this tertiary care center [23].
The limit of viability is considered to be the 
GA at which more than 50% of the newborns 
survive. The Portuguese Neonatal Society, based 
on the National Registry of Very Low Birth 
Weight (VLBW) Infants, has established this 
limit at 25 weeks since 2004 and sensitively at 
500 g of birth weight [24]. In this study, this limit 
was also at 25 weeks of GA. Below this GA, the 
so-called “gray zone” of viability [3], medical 
decisions vary intensively across countries and are 
somewhat controversial, which is a reason why 
they require a careful and individualized analysis 
[3, 4]. In Portugal, palliative care is recommended 
for those born with less than 23 of GA [24]. In 
our study, premature infant born at G23+0-24+6 had 
a 92.6% mortality rate, similar to other studies 
in this center [19, 23], and 44% of them died in 
the first 24 hours after admission in the NICU, in 
line with the EPIPAGE-2 group and other studies 
[23, 25]. This can be explained by decisions to 
withdraw intensive care, which can also justify the 
paradoxical low rates of morbidities in this group 
Table 4. Neonatal morbidity among the survivors.
GA (weeks) Total(n = 100)
23+0-24+6
(n = 2)
25+0-26+6
(n = 27)
27+0-28+6
(n = 71) p
RDS 89 (89.0) 2 (100) 25 (92.6) 62 (87.3) 0.780 a
• Moderate, n (%) 38 (38.0) 1 (50.0) 8 (38.1) 29 (47.5) < 0.0005 b
• Severe, n (%) 25 (25.0) 1 (50.0) 13 (61.9) 11 (18.0)
BPD, n (%) 41 (41.0) 2 (100.0) 19 (70.4) 20 (28.2) < 0.0005 b
• Mild, n (%) 24 (58.5) 1 (50.0) 9 (47.4) 14 (70.0)
• Moderate, n (%) 14 (34.1) 1 (100) 8 (42.1) 5 (25.0) 0.561 b
• Severe, n (%) 3 (7.3) 0 (0.0) 2 (10.5) 1 (5.0)
Pneumonia, n (%) 9 (9.0) 0 (0.0) 8 (29.6) 1 (1.4) < 0.0005 b
Pulmonary hemorrhage, n (%) 1 (1.0) 0 (0.0) 1 (3.7) 0 (0.0) 0.290 b
Pneumothorax, n (%) 4 (4.0) 0 (0.0) 3 (11.1) 1 (1.4) 0.136 b
Sepsis
• Early, n (%) 5 (5.0) 0 (0.0) 2 (7.4) 3 (4.2) 0.652 b
• Late/nosocomial, n (%) 69 (69.0) 2 (100) 20 (74.1) 47 (66.2) 0.663 a
PDA, n (%) 52 (52.0) 2 (100) 17 (63.0) 33 (46.5) 0.108 b
• Medical closure, n (%) 39 (78.0) 2 (100.0) 10 (58.8) 27 (87.1) 0.074 b
• Surgical closure, n (%) 11 (22.0) 0 (0.0) 7 (41.2) 4 (12.9)
NEC ≥ grade 2, n (%) 14 (14.0) 0 (0.0) 3 (11.1) 11 (15.5) 0.817 b
ROP, n (%) 56 (56.0) 2 (100) 21 (77.8) 33 (46.5) 0.04 b
• ≥ grade 2, n (%) 24 (42.9) 1 (50.0) 16 (76.2) 7 (9.9) < 0.0005 b
Brain damage
• IVH, n (%) 44 (44.0) 1 (50.0) 17 (63.0) 26 (36.6) 0.037 b
• ≥ grade 3, n (%) 19 (43.2) 0 (0.0) 9 (52.9) 10 (38.5) 0.524 b
• cPVL, n (%) 10 (10.0) 0 (0.0) 5 (18.5) 5 (7.0) 0.298 b
NICU stay, median (IQR) 70 (55-95) 93 (85-101) 97 (73-109) 63 (49-83) < 0.0005 c
Please note that in some cases data is missing.
BPD: bronchopulmonary dysplasia; cPVL: cystic periventricular leukomalacia; GA: gestational age; IQR: interquartile range; IVH: 
intraventricular hemorrhage; NEC: necrotizing enterocolitis; NICU: Neonatal Intensive Care Unit; PDA: patent ductus arteriosus; RDS: 
respiratory distress syndrome; ROP: retinopathy of prematurity.
a Chi-square test; b Fisher’s exact test; c Kruskal-Wallis test.
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of patients. All these differences explain the great 
variability in mortality in preterm infants at the 
limit of viability.
Another important aspect is the limit of viability 
without major sequelae in more than 50% of 
survivors. In our study, that limit was established 
at 27 weeks.
More than 50% of G23+0-24+6 were twins. 
Multiple pregnancy is related to prematurity and 
in this study it was significantly associated with 
those with less than 24 weeks of GA [26].
In this cohort, a C-section was performed in 
60.6% of all deliveries, and the number increased 
with GA. C-section was not associated with higher 
survival when adjusted to GA, comparably with 
EPICure and EXPRESS groups [27, 28].
Prenatal steroids were previously proven to be 
good for induction of fetal maturation and were 
introduced to medical practices around 1995 [29]. 
Just like in the EXPRESS group study, steroids 
were almost universally administrated (91.6%), 
with 77.3% of mothers receiving a full cycle [30], 
although significantly less at 23 and 24 weeks of 
GA probably due to the doubts about their efficacy 
in those born with 23 weeks of GA.
In this study, 89.4% of the preterm infants 
received IMV without significant difference 
before and after 2010. Although it was expected an 
increase of non-invasive mechanical ventilation in 
recent years, probably these results are explained 
by the low GA of the studied group. Given the 
recent evolution of early respiratory care in the 
delivery room and NICUs, we all should work 
towards reducing the use of IMV.
Extremely preterm newborns within “gray zone” 
GA (G23+0-24+6) were all immediately intubated 
after birth and started mechanical ventilation, just 
like in a study performed in this center [19].
Supplemental oxygen therapy was given to all 
newborns, with a median of 15 days and a maximum 
FiO
2
 of 45%. We must still work towards reducing 
the intensity of oxygen therapy in an attempt to 
decrease morbidity rates [31, 32].
Surfactant therapy was commonly used in 
all neonates but its need in the first hour of life 
decreased with GA, from 78.9% (G23+0-24+6), to 
51.1% (G25+0-26+6) to 40.3% in the last group 
(G27+0-28+6), as expected. We found no relation 
between this therapy and mortality, similar to 
EPICure and EPIBEL studies [26, 27] but in 
contrast with others [28].
Death rates were not affected by surfactant 
therapy or prenatal steroids. However, and as 
expected, the chances of death decreased with 
an increase in GA and birth weight. Based on the 
B value = 0.355, we can calculate and say that 
the chances of death decreased 64.5% for each 
additional week of GA.
Comparing with the Vermont Oxford Network, 
global rates of RDS were very similar and BPD 
had lower rates in our study in contrast with other 
morbidities like PDA, IVH or cPVL which were 
higher in our cohort [21].
Among survivors, care must be taken when 
interpreting data from the G23+0-24+6, as only 
two of them survived. The main morbidities were 
ROP (56%), IVH (44%) and BPD (41%). IVH 
is a major neurologic morbidity and was clearly 
a major cause of death at all ages, accounting for 
30% of them. When comparing the prevalence 
of severe IVH on all patients with its prevalence 
among survivors, we can reinforce its contribution 
to mortality (59.4% vs. 43.2%), also seen in the 
EPIBEL study [26]. This is one of many reasons 
why we should focus further research on how to 
prevent death and neurologic sequelae caused by 
this condition.
Between those who survived, infants born with 
less than 27 weeks of GA needed longer stays 
in the NICU, which can be a risk factor to many 
complications, particularly infectious ones.
One of the three major limitations is the 
retrospective design of the study. Another 
limitation is the small cohort size from a single 
center. We should not generalize the results, 
especially when comparing to larger studies like 
EPICure, EPIBEL, EPIPAGE-2 or EXPRESS 
[25-28]. Large international studies are extremely 
more accurate to draw a conclusion on all these 
practices [33, 34]. Lastly, besides being a single-
center study, is also a tertiary one, which may hold 
some selection bias and we have to be aware when 
comparing it with data from a whole country.
Despite all these limitations, single-center 
studies are nonetheless extremely helpful to the 
physicians who work in NICUs allowing them to 
share experience and consequently improve the 
management of these preterm infants. 
Conclusion
Mortality rates in this preterm group remained 
high in spite of all the technological and scientific 
advances. Pulmonary conditions (RDS and BPD), 
sepsis and neurologic outcomes (ROP, IVH and 
cPVL) are still a major cause of morbidity. In 
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line with other series, the limit of viability in 
this cohort of preterm infants is 25 weeks of GA. 
Prenatal, perinatal and postnatal care still all have 
a long road ahead, especially when it comes to 
these “gray zone” newborns.
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